Home > Artificial Cell Technologies Salary

Artificial Cell Technologies Salary

  • 77
  • 27
  • 29
Artificial Cell Technologies average salary is $64,000, median salary is $64,000 with a salary range from $64,000 to $64,000.
Artificial Cell Technologies salaries are collected from government agencies and companies. Each salary is associated with a real job position. Artificial Cell Technologies salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 1 Artificial Cell Technologies Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Accountant 64,000-64,000 Hyattsville, MD, 20781 2012 Artificial Cell Technologies Accountant Salaries (1)
Artificial Cell Technologies Hyattsville, MD Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Artificial Cell Technologies salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Artificial Cell Technologie... Jobs
See more Artificial Cell Technologies Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
150

All Patents

46

Grant Patents

83

Patents Pending

23

Patents Families

More Recent
Artificial Cell Techno... Information
  • Artificial Cell Technologies, Inc
  • Industry: Biotech/Healthcare
  • City: New Haven, CT
  • Artificial Cell Technologies, Inc. is an early-stage biomedical nanotechnology company founded in 2002 to commercialize applications of a new proprietary technology platform involving designed polypeptides. Our long term vision is to commercialize biotechnology applications for successively more sophisticated versions of an artificial bionanomachine: the artificial cell. ACT was founded to achieve this artificial cell vision by commercializing biomedical applications of our proprietary polypeptide nanostructure technology platform, starting with one of the simplest of human cells, the red blood cell. ACT¡¯s technology platform includes proprietary methods for manufacturing custom-designed polypeptide films and microcapsules with controlled, tunable